NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-357-2001-1-AU-16 Construction of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virus AU DIV 2013213749 Abandoned
NIAID E-081-2013-3-US-01 PREFUSION RSV F PROTEINS AND THEIR USE US 61/863,909 Abandoned
NHLBI E-037-2011-0-US-03 Development Of A Novel HDL Based Hydrophobic Drug Delivery System Using Amphipathic Peptides US ORD 13/961,296 9314532 Issued PDF
NHLBI E-037-2011-0-PCT-02 Development Of A Novel HDL Based Hydrophobic Drug Delivery System Using Amphipathic Peptides PCT PCT PCT/US2013/053953 Expired
NHLBI E-037-2011-0-EP-06 Development Of A Novel HDL Based Hydrophobic Drug Delivery System Using Amphipathic Peptides EP National Stage 13751004.6 Abandoned
NHLBI E-553-2013-0-US-01 Aortic Access From Vena Cava for Large Caliber Transcatheter Cardiovascular Interventions US 61/863,071 Abandoned
NHLBI E-037-2011-0-AU-08 Development Of A Novel HDL Based Hydrophobic Drug Delivery System Using Amphipathic Peptides AU National Stage 2013299641 Abandoned
NHLBI E-037-2011-0-CA-05 Development Of A Novel HDL Based Hydrophobic Drug Delivery System Using Amphipathic Peptides CA National Stage 2881440 Pending
NCI E-080-2008-0-US-04 Human Monoclonal Antibodies Specific For CD22 US DIV 13/959,061 9279019 Issued PDF
NCI E-286-2006-2-US-04 Therapeutic Use of SCGB3A2 US CON 13/959,628 8828936 Issued PDF
NCI E-286-2006-3-US-01 SCGB3A2 for Treatment of Cancer US 61/862,429 Abandoned
NCATS E-050-2012-0-GB-01 Cyclodextrin For The Treatment Of Lysosomal Storage Diseases GB EP 13762617.2 Issued
NCATS E-050-2012-0-EP-06 Cyclodextrin For The Treatment Of Lysosomal Storage Diseases EP National Stage 13762617.2 Issued
NCATS E-050-2012-0-CA-04 Cyclodextrin For The Treatment Of Lysosomal Storage Diseases CA National Stage 2880880 Issued
NCATS E-050-2012-0-PCT-02 Cyclodextrin For The Treatment Of Lysosomal Storage Diseases PCT PCT PCT/US2013/053527 Expired
NCATS E-050-2012-0-CN-05 Cyclodextrin For The Treatment Of Lysosomal Storage Diseases CN National Stage 201380052023.0 Abandoned
NCATS E-050-2012-0-JP-07 Cyclodextrin For The Treatment Of Lysosomal Storage Diseases JP National Stage 2015-525640 Abandoned
NCATS E-050-2012-0-AU-03 Cyclodextrin For The Treatment Of Lysosomal Storage Diseases AU National Stage 2013296170 Abandoned
NHLBI E-250-2010-0-US-04 Lightguides To Simplify Total Emission Detection For Multiphoton Microscopy US National Stage 13/983,534 9448158 Abandoned PDF
NCI E-294-2010-0-US-03 Pharmaceutical Composition Comprising NANOG SHRNA, and Method of Using NANOG SHRNA to Treat Cancer US National Stage 13/991,989 9163236 Issued PDF
NCI E-014-2007-0-CN-28 SMOOTHENED POLYPEPTIDES AND METHODS OF USE CN DIV 201310334389.9 Abandoned
NCI E-255-2012-0-PCT-02 REVERSIBLE REGULATION OF INTEIN ACTIVITY THROUGH ENGINEERED NEW ZINC BINDING DOMAIN PCT PCT PCT/US2013/053195 Expired
NCI E-014-2007-0-US-27 Smoothened Polypeptides and Methods of Use US DIV 13/956,628 Abandoned
NIAID E-357-2001-1-JP-14 Construction of West NIle Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused by West Nile Virus JP DIV 2013-160104 Abandoned
NCI E-508-2013-0-US-01 Inhibitors of the Farnesoid X Receptor and Use Thereof in the Prevention of Weight Gain US 61/861,109 Abandoned
NIAID E-057-2011-2-US-02 Virus-Like Particles And Methods Of Use US National Stage 13/982,986 9487563 Issued PDF
NIDDK E-538-2013-0-US-01 Improved ELISA To Measure Hyaluronan US 61/860,722 Abandoned
NCI E-551-2013-0-PCT-02 Combination Therapty For The Treatment Of Cancer PCT PCT PCT/US2013/052670 Expired
NHGRI E-013-2011-0-US-03 TRRAP And GRIN2A Mutations and Use Thereof for the Diagnosis and Treatment of Melanoma US National Stage 13/982,392 9157125 Issued PDF
NINDS E-030-2013-0-US-01 Selective Dopamine D2 Receptor Antagonists And Methods Of Their Use US 61/859,532 Abandoned
NCI E-166-2007-0-US-06 FILIP1L Nucleic Acid Fragments US DIV 13/952,192 9279009 Issued PDF
NCI E-029-2006-1-JP-13 Novel Indenoisoquinoline Derivatives As Anti-proliferative Agents In Cancer Treatment JP DIV 2013-155750 Issued
NCI E-071-2009-0-US-04 Methods to Diagnose and Immunize Against the Virus Causing Human Merkel Cell Carcinoma US DIV 13/951,679 9156888 Issued PDF
NCI E-033-2008-0-US-07 Therapeutic Applications Of A P53 Isoform In Regenerative Medicine, Aging And Cancer US DIV 13/952,561 9068165 Abandoned PDF
NIAID E-021-2019-0-US-01 CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN US 61/858,533 Abandoned
NIAID E-120-2001-0-IN-84 Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses IN DIV 6683/DELNP/2013 Expired
NIAID E-081-2013-2-US-01 Prefusion RSV F Proteins And Their Use US 61/857,613 Abandoned
NHLBI E-322-2007-0-CA-04 COMPOSITIONS CONTAINING NUCLEOSIDES AND MANGANESE AND THEIR USES CA National Stage 2695950 Issued
NCI E-215-2007-0-AU-12 Methods for Determining Hepatocellular Carcinoma Subtype and Detecting Hepatic Cancer Stem Cells AU DIV 2013207631 Abandoned
NCI E-014-2007-0-JP-26 SMOOTHENED POLYPEPTIDES AND METHODS OF USE JP DIV 2013-150706 Abandoned
NICHD E-167-2009-3-US-02 METHODS FOR TREATMENT OF AUTISM SPECTRUM DISORDER US ORD 13/945,384 8987246 Issued PDF
NIAID E-540-2013-0-US-01 Methods and Compositions for Prevention of Allergic Reaction US 61/847,766 Abandoned
NCI E-157-2012-0-CA-05 Nitric Oxide Releasing Diazeniumdiolated Polyvinylpyrrolidone Based Polymers, and Compositions, Medical Devices, and Uses Thereof CA National Stage 2879843 Issued
NCI E-157-2012-0-EP-06 Nitric Oxide Releasing Diazeniumdiolated Polyvinylpyrrolidone Based Polymers, and Compositions, Medical Devices, and Uses Thereof EP National Stage 13819293.5 Abandoned
NCI E-157-2012-0-AU-03 Nitric Oxide Releasing Diazeniumdiolated Polyvinylpyrrolidone Based Polymers, and Compositions, Medical Devices, and Uses Thereof AU National Stage 2013292695 Issued
NIAID E-203-2010-0-JP-07 Methods for Amplification and Detection of Prions JP National Stage 2013-550540 Abandoned
NIEHS E-012-2011-0-US-03 Modulation of LRCH4 Activity and Therapeutic Application Thereof US National Stage 13/980,097 9211302 Issued PDF
NCI E-157-2012-0-PCT-02 Nitric Oxide Releasing Diazeniumdiolated Polyvinylpyrrolidone Based Polymers, and Compositions, Medical Devices, and Uses Thereof PCT PCT PCT/US2013/050793 Expired
NHLBI E-175-2012-0-PCT-02 Method of Preparing Silca-Coated Nanodiamonds PCT PCT PCT/US2013/050779 Expired
NHLBI E-175-2012-0-EP-05 Method of Preparing Silca-Coated Nanodiamonds EP National Stage 13819376.8 Abandoned